...
首页> 外文期刊>Archivio Italiano di Urologia e Andrologia >Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy
【24h】

Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy

机译:他达拉非治疗保留开放性神经的前列腺癌根治术后的结果

获取原文

摘要

Purpose: To evaluate the effect of postoperatively administering a low daily dose of tadalafil on the erectile function of patients who underwent a nerve-sparing radical prostatectomy(NSRP) due to localized prostate cancer (PCa). Materials and Methods: Of 138 patients, who underwent NSRP due to PCa between 2012 and 2014, 55 patients who had not had pre-operative erectile dysfunction (ED) were included in the study. The mean age of the patients was 64 (54-72). On the 15th day after surgery, after ultrasound evaluation, all 55 patients started on a daily dose of 5 mg tadalafil that was continued for 2.5 months. The erectile function of patients was evaluated pre-operatively, post-operatively, and at the 3rd and 6th month after surgery using the International Index of Erectile Function (IIEF-5) test. None of the patients was treated with hormonal therapy or radiotherapy before or after surgery. Results: Three patients were excluded from the study due to the adverse effects of tadalafil and two patients elected to discontinue the treatment. Of the remaining 50 patients whose pre-operative erectile function had been found normal, at 3 months after surgery, 36 (72%) had normal erectile function; of the remaining patients in the study six (12%) presented with mild, two (4%) with moderate, and six (12%) with severe ED. Six months after surgery, 35 patients (70%) had normal erectile function while seven (14%) had mild, three (6%) moderate and five (10%) severe ED. There was no statistically significant difference between the results obtained at the 3rd and 6thmonth follow-up (p > 0.05). Three patients reported adverse effects with tadalafil including flushes in 2 (3.6%) and a headache in 1 (1.8%). Conclusions: The administration of a 5 mg post-operative dose of tadalafil to patients that had undergone a bilateral NSRP was found to have a positive effect on the recovery and maintenance of erectile function. However, there is still a need to investigate a larger series of cases.
机译:目的:评估术后因局部前列腺癌(PCa)而接受神经保护性根治性前列腺切除术(NSRP)的患者每日服用低剂量他达拉非对勃起功能的影响。资料与方法:在2012年至2014年间因PCa而接受NSRP的138例患者中,有55例未出现术前勃起功能障碍(ED)的患者。患者的平均年龄为64岁(54-72岁)。手术后第15天,经过超声评估后,所有55名患者开始接受5 mg他达拉非的每日剂量,并持续2.5个月。使用国际勃起功能指数(IIEF-5)测试对患者的勃起功能进行评估,包括术前,术后以及术后第3和第6个月。手术前后均未接受激素疗法或放射疗法的患者。结果:由于他达拉非的不良反应,三名患者被排除在研究之外,另两名患者选择中止治疗。其余50例术前勃起功能正常的患者,在术后3个月中,有36例(72%)勃起功能正常。在研究的其余患者中,有六名(12%)表现为轻度,二名(4%)为中度,六名(12%)为严重ED。术后六个月,有35例(70%)勃起功能正常,而七例(14%)轻度,三例(6%)中度和五例(10%)严重ED。在第3个月和第6个月的随访中获得的结果之间没有统计学显着性差异(p> 0.05)。三名患者报告了他达拉非的不良反应,包括潮红2例(3.6%)和头痛1例(1.8%)。结论:对接受双侧NSRP治疗的患者术后给予5 mg他达拉非的剂量对勃起功能的恢复和维持具有积极作用。但是,仍然需要调查更多的案件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号